Biond Biologics Ltd.
Records under this name other than the patents Biond Biologics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| 17/438,634 | A Method for Immunosuppression Abandoned Abandoned Apr 19, 2025 | Abandoned | Abandoned Apr 19, 2025 | |
| 17/781,966 | Soluble CD28 Levels During Immunotherapy Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 17/915,761 | Immunomodulatory Compostions and Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/124,717 | Soluble CD28 Levels After Immunotherapy Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/653,316 | Intracellular Delivery Compositions Abandoned Abandoned Aug 21, 2026 | Abandoned | Abandoned Aug 21, 2026 | |
| 18/689,483 | CD28 Shedding Blocking Agents Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/735,940 | Methods and Compositions for Decreasing Soluble Immune Receptor CD28 Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/770,474 | Treatment of Cancer with ANTI-ILT2 Antibodies now held by Genzyme Corporation Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/858,887 | ANTI-ILT3 Antibodies and Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/260,267 | Antibodies Against ILT2 and Use Thereof Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |